1 July 2022 - Gene and cell therapy company Oxford Biomedica plc (LSE:OXB) announced on Friday the signing of a new three-year agreement with pharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN).This Master Services & Developme...
1 July 2022 - Myeloid Therapeutics, Inc., a US-based clinical stage mRNA-immunotherapy company, announced on Thursday that it has added Stanley Frankel, M.D., FACP and Brett Brett Kaplan, MD to its board of directors.Dr Frankel has over 20 years of i...
1 July 2022 - Phanes Therapeutics, Inc., a US-based company involved in oncology discovery, research and clinical development, announced on Thursday that it has received orphan drug designation from the US Food and Drug Administration (FDA) for PT886...
1 July 2022 - Aristea Therapeutics, a US-based clinical-stage immunology focused drug development company advancing novel therapies to treat serious inflammatory diseases, announced on Thursday that it has dosed its first patient in the open-label ex...
1 July 2022 - Vivera Pharmaceuticals, a US-based pharmaceutical company, announced on Thursday that it has added Guido Jouret, PhD to the company's board of advisors as senior technology advisor and interim chief technology officer.Dr Jouret has...